Tenax Therapeutics (TENX) Notes Payables (2011 - 2024)
Tenax Therapeutics (TENX) reported Notes Payables of $278802.0 for Q2 2024, down 19.36% on a YoY basis from $345749.0 in Q3 2023, and down 32.52% sequentially from $413174.0 in Q1 2024.
Tenax Therapeutics (TENX) Notes Payables (2011 - 2024) Analysis & Trends
Tenax Therapeutics (TENX) has 8 years of Notes Payables data on file, last reported at $278802.0 in Q2 2024.
- For the quarter ending Q2 2024, Notes Payables fell 19.36% year-over-year to $278802.0; the trailing twelve-month figure through Jun 2024 stood at $278802.0 (down 19.36% YoY), and the FY2023 full-year result was $501000.0, down 19.75% from the prior year.
- Notes Payables eased to $278802.0 in Q2 2024, from $413174.0 in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $624302.0 in Q4 2022 to a low of $30900.0 in Q3 2020.
- A 5-year average of $280354.6 and a median of $228762.0 in 2022 frame the typical range for Notes Payables.
- Peak annual rise in Notes Payables reached 276.33% in 2023, while the deepest fall reached 19.75% in 2023.
- Tracing TENX's Notes Payables over 5 years: stood at $120491.0 in 2020, then soared by 77.26% to $213577.0 in 2021, then surged by 192.31% to $624302.0 in 2022, then declined by 19.75% to $501000.0 in 2023, then plunged by 44.35% to $278802.0 in 2024.
- Business Quant data shows TENX's Notes Payables at $278802.0 in Q2 2024, $413174.0 in Q1 2024, and $501000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Tenax Therapeutics | 67,856.40 | 67,856.40 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 278,802.00 |
| Mar 31, 2024 | 413,174.00 |
| Dec 31, 2023 | 501,000.00 |
| Sep 30, 2023 | 174,466.00 |
| Jun 30, 2023 | 345,749.00 |
| Mar 31, 2023 | 513,906.00 |
| Dec 31, 2022 | 624,302.00 |
| Jun 30, 2022 | 91,875.00 |
| Mar 31, 2022 | 228,762.00 |
| Mar 31, 2021 | 213,577.00 |
| Dec 31, 2020 | 120,491.00 |
| Sep 30, 2020 | 30,900.00 |
| Jun 30, 2020 | 107,606.00 |
| Apr 30, 2013 | 57,539.00 |
| Jan 31, 2013 | 98,657.00 |
| Oct 31, 2012 | 7,195.00 |
| Jul 31, 2012 | 21,223.00 |
| Apr 30, 2012 | 62,958.00 |
| Jan 31, 2012 | 104,178.00 |
| Oct 31, 2011 | 7,195.00 |